TickerFactsScreenerDevelopers

REGENXBIO Inc. (RGNX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$48.56M2017: -$57.99M2018: $104.65M2019: -$107.70M2020: -$54.06M2021: $218.88M2022: -$207.49M2023: -$218.41M2024: -$173.12M2025: -$123.96M-$123.96M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$123.96M+28.4%
2024-$173.12M+20.7%
2023-$218.41M-5.3%
2022-$207.49M-194.8%
2021$218.88M+504.9%
2020-$54.06M+49.8%
2019-$107.70M-202.9%
2018$104.65M+280.5%
2017-$57.99M-19.4%
2016-$48.56M—